welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, and Marina Biotech, Inc., a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that the companies have executed a term sheet under which Microlin intends to acquire Marina’s nucleic acid therapeutics assets.
expertly curated content related to this topic
-
Daniel G. Luba, MDCurrent Positions: Medical Director o...
-
Non-Invasive Prediction of Colorectal NeoplasiaHypothesis:The Adnab-9 antigen is a ...
-
Sonia Kupfer, MDSonia Kupfer, MD, is an expert in digest...
-
young adults and kids living with fap, afapGrowing up knowing about FAP (familial A...
-
St. Mark’s Hospital/Polyposis RegistryPatient Resources: Polyposis Regist...
-
James R. Howe V, MDJames R. Howe V, MD is a Surgical Oncolo...
-
Lisen Axell, MS, CGCGenetic Counselor Lisen Axell has ...